Atox Bio

Atox Bio is a clinical-stage biotechnology company dedicated to developing treatments for diseases mediated by dysregulated inflammatory responses. Atox Bio focuses on novel modulators of the immune response, targeting key multiplex and interconnected pathways of both adaptive and innate immune responses, which play a crucial role in infectious and inflammatory diseases as well as ischemia/reperfusion injury.